You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Litigation Details for AbbVie Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2014)

✉ Email this page to a colleague

« Back to Dashboard

AbbVie Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2014)

Docket	⤷ Try a Trial	Date Filed	2014-10-09
Court	District Court, D. Delaware	Date Terminated	2015-10-07
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Parties	ABBVIE INC.
Patents	7,148,359; 7,364,752; 8,268,349; 8,399,015; 8,470,347; 8,691,878
Attorneys	Jessica M. Hauth
Firms	Polsinelli PC
Link to Docket	External link to docket

Small Molecule Drugs cited in AbbVie Inc. v. Mylan Pharmaceuticals Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .

Details for AbbVie Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2014)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2015-02-09	33		Plaintiffs' Notice of Asserted Claims of U.S. Patent No. 7,364,752 and (2) Plaintiffs' Initial Infringement…2014 7 October 2015 1:14-cv-01288 830 Patent None District Court, D. Delaware	External link to document
2014-10-09	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359 B2; 7,364,752 B1; (…2014 7 October 2015 1:14-cv-01288 830 Patent None District Court, D. Delaware	External link to document
2015-10-07	62		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359 B2; 7,364,752 B1; 8,268,349…2014 7 October 2015 1:14-cv-01288 830 Patent None District Court, D. Delaware	External link to document
2014-10-15	8		Expiration of Patent: Patent No. 7,148,359: July 19, 2019; Patent No. 7,364,752: November 10, 2020; Patent No. …21, 2011 for Patent Numbers 7,148,359 and 7,364,752; On or about October 8, 2014 for Patent Numbers 8,268,349…25, 2024; Patent No. 8,399,015: August 25, 2024; Patent No. 8,470,347: Sept. 17, 2026; Patent No. 8,691,878… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2014 7 October 2015 1:14-cv-01288 830 Patent None District Court, D. Delaware	External link to document
2014-10-15	9		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359 B2; 7,364,752 B1; 8,268,349…2014 7 October 2015 1:14-cv-01288 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.